Abstract
We evaluated the response to the QuantiFERON TB-2G (QFT-2G) test in patients with healed pulmonary tuberculosis (TB) compared to the response in those with active pulmonary TB. The subjects were 208 patients with healed pulmonary TB and 155 patients with active pulmonary TB. The QFT-2G test results were analyzed by stratifying them into 5- or 10-year periods after the completion of antituberculosis treatment. Of the 208 patients with healed pulmonary TB, 63% had a positive tuberculin skin test (TST) and 34% had a positive QFT-2G test result. There was no significant difference in the positive response rate for the QFT-2G test, or in the positive test result rate for only the early secretory antigenin target 6-kD protein (ESAT-6) antigen, only the culture filtrate protein 10 (CFP-10) antigen, or both the ESAT-6 and CFP-10 antigens among any subgroups stratified by 5- or 10-year periods after the completion of antituberculosis treatment. The positive rate for the QFT-2G test was significantly higher in patients with active pulmonary TB (83%) than in patients with healed pulmonary TB (34%). Regarding the combined and separate responses to both the ESAT-6 and CFP-10 antigens, the positive response rate for both antigens was significantly lower in patients with healed pulmonary TB than in those with active pulmonary TB. Because many patients continued to show a positive response to the QFT-2G test even when a long period had passed after the completion of the antituberculosis treatment, it is suggested that, in patients with a previous history of TB, particular attention must be paid to the relapse of TB or reinfection with TB.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356:1048–1049.
Lalvani A, Pathan AA, McShane H, Wilkinson RJ, Latif M, Conlon CP, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001;163:824–828.
Pai M, Riley LW, Colfors JM. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761–776.
Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Verman A, et al. Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention. Guidelines for using the QuantiFERONTB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54:49–55.
Rothel JS, Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 2005;3:981–993.
American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S21–247.
Kobashi Y, Sugiu T, Ohue Y, Mouri K, Obase Y, Miyashita N, et al. Long-term follow-up of the QuantiFERON TB-2G test for active tuberculosis disease. Intern Med 2008;47:1957–1961.
Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Karantri S, et al. Serial testing of health care workers for tuberculosis using interferon-γ assay. Am J Respir Crit Care Med 2006;174:349–355.
Chee CB, KhinMar KW, Gan SH, Barkham TM, Pushparani M, Wang YT. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 2007;175:282–287.
Pai M, Joshi R, Bandyipadhyay M, Narang P, Dogra S, Taksande B, et al. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculous treatment. Infection 2007;35:98–103.
Kobashi Y, Mouri K, Yagi S, Obase Y, Miyashita N, Okimoto N, et al. Clinical utility of the QuantiFERON TB-2G test for elderly patients with active tuberculosis. Chest 2008;133:1196–1202.
Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EE, Reddy MV, et al. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. PLoS ONE 2008;26:e1850.
Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006;174:736–742.
Harada N, Higuchi K, Yoshiyama T, Kawabe Y, Fujita A, Sasaki Y, et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 2008;56:348–353.
Author information
Authors and Affiliations
About this article
Cite this article
Kobashi, Y., Shimizu, H., Mouri, K. et al. Clinical evaluation of QuantiFERON TB-2G test in patients with healed pulmonary tuberculosis. J Infect Chemother 15, 288–292 (2009). https://doi.org/10.1007/s10156-009-0706-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10156-009-0706-8